Studies on Treatment Effects and Prognoses of Adoptive Immunotherapy of Cancer Patients by using autologous and allogeneic lymphocytes.
Studies on Treatment Effects and Prognoses of Adoptive Immunotherapy of Cancer Patients by using autologous and allogeneic lymphocytes.
批准号:
06671888
负责人:
KUBOTA Eiro
金额:
$1.22万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Culture of peripheral blood mononuclear cells (PBMC) with a heat and penicillin-treated streptococcal preparation, OK-432, has induced effector cells which have both cell-mediated and cytokine-mediated antitumor activities. We performed locoregional adoptive immunotherapy (AIT) with OK-432-activated PBMC (OKMC) in head and neck cancer patients as a part of preoperative treatment. In the present study we evaluated the correlation of tumor mononuclear cell infiltration and patient's prognosis. The AIT group (10 cases) was more abundant in infiltrating T cells (UCHL-1+) in tumor tissue than those of the non-AIT group (10 cases). There were three recurrences out of 10 cases of AIT group, in which a small number of OKMC was transferred and had much less T cell infiltration of the tumor parenchyma.Tumor tissues were surgically excised and therapeutic effect was examined histologically. In AIT group, focal necrosis of cancer tissue was observed at the site of OKMC injection especially at the portion of massive infiltration of mononuclear cells. These cell death was characteristic of apoptosis as examined by HE and immunohistochemical staining with anti-Le^y antibody. Various kind of cytokine mRNAs including IL-1, TNFalpha, IL-6, IFNgamma, IL-2, IL-4 were also detected in the tumor burden by RT-PCR technique. The IL-1 and IL-2 mRNA were detected in almost all of the tumor tissue, but IFNgamma was found only in 50% of these cases. Furthermore, tumor tissue which lack the IFNgamma message was unequivocally expressed immunosuppressive cytokine IL-10. The IFNgammamRNA was reappeared after the AIT in the tumor tissue which could not be detected its message before AIT.The above mentioned phenomena were presumed to be direct effect of AIT.Thus, it is considered that local administration of OKMC could be one of the most feasible BRM therapies in head and neck cancers.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Katano M: "Inhibition of fumor cell growth by a human B-cell line" Biotherapy. 8. 1-6 (1995)
Katano M:“人类 B 细胞系抑制肿瘤细胞生长”生物疗法。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hu ZL: "Effective induction of human NK cells with OK-432 and further augmentation of their cytolytic function by rIL-2" Microbiol Immunol. 38. 183-190 (1994)
Hu ZL:“用 OK-432 有效诱导人类 NK 细胞,并通过 rIL-2 进一步增强其细胞溶解功能”Microbiol Immunol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katano M,Matsuo T,Morisaki T,Naito K,Nagumo F,Kubota E,Nakamura M,Hisatsugu T,and Tadano J: "Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2." Cancer Immunol Immunother. 39. 161-166 (1994)
Katano M、Matsuo T、Morisaki T、Naito K、Nagumo F、Kubota E、Nakamura M、Hisatsugu T 和 Tadano J:“通过重组白细胞介素 2 增加人乳腺癌细胞系的增殖。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katano M,Kubota E,Nagumo F,Matsuo T,Hisatsugu T,and Tadano J: "Inhibition of tumor cell growth by a human B-cell line" Biotherapy. 8. 1-6 (1995)
Katano M、Kubota E、Nagumo F、Matsuo T、Hisatsugu T 和 Tadano J:“人类 B 细胞系对肿瘤细胞生长的抑制”生物疗法。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katano M,Matsuo T,Morisaki T,Naito K,Nagumo F,Kubota E,Nakamura M,Hisatsugu T,and Tadano J: "Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2" Cancer Immunol Immunother. 39. 161-166 (1995)
Katano M、Matsuo T、Morisaki T、Naito K、Nagumo F、Kubota E、Nakamura M、Hisatsugu T 和 Tadano J:“通过重组白细胞介素 2 增加人乳腺癌细胞系的增殖”癌症免疫免疫疗法。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
Study on a new combination chemotherapy for head and neck squamous cell carcinomas
-
批准号:21390543
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:KUBOTA Eiro
-
依托单位:
Study on matrix metalloproteinase activities and cartilage degradation of the temporomandibular joint
-
批准号:11470400
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.95万
-
财政年份:1999
-
负责人:KUBOTA Eiro
-
依托单位:
Study for the diagnosis of early cartilage degradation in the patient with TMJ internal derangement
-
批准号:08457557
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.8万
-
财政年份:1997
-
负责人:KUBOTA Eiro
-
依托单位:
Studies on Adoptive Immunotherapy Utilizing Allogeneic Spleen Cells Against Cancers
-
批准号:03670949
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1991
-
负责人:KUBOTA Eiro
-
依托单位:
海外基金